- CCHR Australia - https://cchr.org.au -

New Australian Clinical Practice Points (CPPs) on ADHD could see Children Removed from their Parents if they Refuse to “Treat their Child’s ADHD”

Boy holding the label ADHD in front of his chestAn extremely concerning statement in the CPPs on ADHD indicates that Australia could now be following the US model where children can be removed from their parents if they refuse to give their child ADHD drugs. On page 15 of the CPPs it states, “As with any medical intervention, the inability of the parents to implement strategies may raise child protection concerns.”

Please do a submission to protect our children and express your objections by 28th November 2011

By the end of 2010 there were already more than 52,000 children aged between 2 and 16 on ADHD drugs in Australia. The stimulants and antidepressants used to “treat” ADHD are known to cause hallucinations, delusions, heart problems, high blood pressure and suicidal reactions.

A new and additional document has just been drafted by a panel of experts titled, Clinical Practice Points on Attention Deficit Hyperactivity in Children and Adolescents (CPPs). These have been written to “complement” (not replace) the ADHD Guidelines and will also be an interim measure while the validity  of the current Draft ADHD Guidelines is verified. There are well meaning experts on this new panel for the CPPs.  The Draft ADHD Guidelines were halted earlier this year due to conflicts of interest of psychiatrist Joseph Biederman whose work was heavily citied in the Draft ADHD Guidelines. Biederman was sanctioned after allegedly failing to report $1.6 million in consulting fees he received from drug companies. The National Health and Medical Research Council will meet in early December 2011 to decide if they will scrap the draft ADHD Guidelines and send them back to the Royal Australasian College of Physicians for a re-write or if they will approve them for use.

These CPP’s  “clarify best practice diagnosis” while at the same time denying there is any evidence that many proven, workable and non-harmful alternatives work and help our children.  The CPPs will remain in use once the ADHD Guidelines are completed.

Major areas of concern in the CPPs for ADHD include:

Conflicts of Interest:

To Make a Submission:

The correct Submission Form (coversheet)  MUST be used or your submission will not be accepted.

Online: Log onto the National Health and Medical Research Website at: http://consultations.nhmrc.gov.au/open_public_consultations/a-d-h-d to read the CPPS for ADHD and make a submission.    You can obtain a submission form (coversheet) which you will need no matter how you lodge your submission on the same link.   See  near the bottom of the page.  The easiest way to lodge a submission is to down load the coversheet, write your submission under the coversheet and then email it to the below email.

Email: adhdcpps@nhmrc.gov.au

Mail: Project Officer – Draft ADHD CPPs, Strategic Partnership Section, NHMRC, GPO Box 1421, Canberra ACT 2601.

Fax: (02) 6217 9035


[1] DRAFT Clinical Practice Points on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents, NHMRC, October, page 15.

[2] DRAFT Clinical Practice Points on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents, NHMRC, October, pages 7, 12.

[3] DRAFT Clinical Practice Points on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents, NHMRC, October, page 4.

[4] DRAFT Clinical Practice Points on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents, NHMRC, October, page 16.

[5] http://www.med.monash.edu.au/spppm/research/devpsych/srp.html

[6] http://www.nhmrc.gov.au/guidelines/adhd-conflicts-interest

[7] http://www.nhmrc.gov.au/guidelines/adhd-conflicts-interest

[8] DRAFT Clinical Practice Points on Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents, NHMRC, October, page 20.